Literature DB >> 27039932

Au@MnS@ZnS Core/Shell/Shell Nanoparticles for Magnetic Resonance Imaging and Enhanced Cancer Radiation Therapy.

Meifang Li1, Qi Zhao1, Xuan Yi1, Xiaoyan Zhong1, Guosheng Song2, Zhifang Chai1, Zhuang Liu2, Kai Yang1.   

Abstract

Although conventional radiotherapy (RT) has been widely used in the clinic to treat cancer, it often has limited therapeutic outcomes and severe toxic effects. There is still a need to develop theranostic agents with both imaging and RT-enhancing functions to improve the accuracy and efficiency of RT. Herein we synthesize Au@MnS@ZnS core/shell/shell nanoparticles with polyethylene glycol (PEG) functionalization, yielding Au@MnS@ZnS-PEG nanoparticles with great stability in different physiological solutions and no significant cytotoxicity. It is found that Au@MnS@ZnS-PEG nanoparticles can enhance the cancer cell killing efficiency induced by RT, as evidenced by multiple in vitro assays. Owing to the existence of paramagnetic Mn(2+) in the nanoparticle shell, our Au@MnS@ZnS-PEG can be used as a contrast agent for T1-weighted magnetic resonance (MR) imaging, which reveals the efficient accumulation and retention of nanoparticles in the tumors of mice after intravenous injection. Importantly, by exposing tumor-bearing mice that were injected with Au@MnS@ZnS-PEG to X-ray irradiation, the tumor growth can be significantly inhibited. This result shows clearly improved therapeutic efficacy compared to RT alone. Furthermore, no obvious side effect of Au@MnS@ZnS-PEG is observed in the injected mice. Therefore, our work presents a new type of radiosensitizing agent, which is promising for the imaging-guided enhanced RT treatment of cancer.

Entities:  

Keywords:  MR imaging; cancer treatment; core−shell−shell structure; enhanced radiotherapy; multifunctional nanoplatforms

Mesh:

Substances:

Year:  2016        PMID: 27039932     DOI: 10.1021/acsami.5b11588

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  7 in total

Review 1.  Smart Nanostructures for Cargo Delivery: Uncaging and Activating by Light.

Authors:  Mahdi Karimi; Parham Sahandi Zangabad; Soodeh Baghaee-Ravari; Mehdi Ghazadeh; Hamid Mirshekari; Michael R Hamblin
Journal:  J Am Chem Soc       Date:  2017-03-13       Impact factor: 15.419

2.  Implementation of surface functionalization of MnS nanoparticles for achieving novel optical properties and improving therapeutic potential.

Authors:  Arpan Bera; Md Nur Hasan; Nivedita Pan; Ria Ghosh; Reem A Alsantali; Hatem M Altass; Rami J Obaid; Saleh A Ahmed; Samir Kumar Pal
Journal:  RSC Adv       Date:  2022-07-19       Impact factor: 4.036

3.  Intracellular Delivery of Doxorubicin by Iron Oxide-Based Nano-Constructs Increases Clonogenic Inactivation of Ionizing Radiation in HeLa Cells.

Authors:  Roxana Cristina Popescu; Diana Iulia Savu; Miriam Bierbaum; Adriana Grbenicek; Frank Schneider; Hiltraud Hosser; Bogdan Ștefan Vasile; Ecaterina Andronescu; Frederik Wenz; Frank A Giordano; Carsten Herskind; Marlon R Veldwijk
Journal:  Int J Mol Sci       Date:  2021-06-24       Impact factor: 5.923

Review 4.  Metal-based NanoEnhancers for Future Radiotherapy: Radiosensitizing and Synergistic Effects on Tumor Cells.

Authors:  Yan Liu; Pengcheng Zhang; Feifei Li; Xiaodong Jin; Jin Li; Weiqiang Chen; Qiang Li
Journal:  Theranostics       Date:  2018-02-12       Impact factor: 11.556

Review 5.  Magnetic polymeric nanoassemblies for magnetic resonance imaging-combined cancer theranostics.

Authors:  Shenglong Gan; Yisheng Lin; Yancong Feng; Lingling Shui; Hao Li; Guofu Zhou
Journal:  Int J Nanomedicine       Date:  2018-07-23

Review 6.  Remotely Activated Nanoparticles for Anticancer Therapy.

Authors:  Luisa Racca; Valentina Cauda
Journal:  Nanomicro Lett       Date:  2020-10-27

Review 7.  Nanoparticles as a Tool in Neuro-Oncology Theranostics.

Authors:  Andrea L Klein; Grant Nugent; John Cavendish; Werner J Geldenhuys; Krishnan Sriram; Dale Porter; Ross Fladeland; Paul R Lockman; Jonathan H Sherman
Journal:  Pharmaceutics       Date:  2021-06-24       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.